Last edition
News about Manufacturing
AbbVie and RemeGen, a China-based innovative biopharmaceutical company, have entered into an exclusive licensing agreement covering the development, manufacturing, and commercialization of RC148, a novel investigational PD-1/VEGF-targeted bispecific antibody for the treatment of advanced solid tumours.
Manufacturing | 13/01/2026 | By Darshana | 165
Aragen Introduces CHOMax for Rapid IND-Enabling Clinical Supply
Aragen has launched CHOMax, a fully integrated and royalty-free platform designed to accelerate the journey from DNA to IND-enabling clinical supply in approximately 10 months, combining cell line development, process and analytical development and GMP manufacturing with demonstrated high-performance outcomes.
Manufacturing | 13/01/2026 | By News Bureau | 174
Novartis to Add Fourth US Radioligand Therapy Plant in Florida
Novartis will expand its US radioligand therapy manufacturing network with a new purpose-built facility in Winter Park, Florida, strengthening patient access across the southeastern US and supporting the company’s broader USD 23 billion investment in advanced manufacturing and oncology innovation.
Manufacturing | 12/01/2026 | By News Bureau | 272
Sharp Sterile Manufacturing Expands Capacity Via USD 28 Million Investment
With the new investment, Sharp Sterile Manufacturing aims to scale up throughput by adding an automated isolated filling line to support faster batch production.
Manufacturing | 08/01/2026 | By News Bureau | 177
Intelligent Bio Solutions Inc (INBS), a medical technology company focused on rapid, non-invasive testing solutions, has entered into a strategic manufacturing partnership with Syrma Johari MedTech Ltd to scale production of its Intelligent Fingerprinting Drug Screening Reader and support long-term margin expansion.
Manufacturing | 03/01/2026 | By Darshana | 229
A New Year, A New Chapter for Pharma Manufacturing in India
As India steps into a new year, the pharmaceutical manufacturing sector stands at a defining crossroads. Over the past few years, Indian pharma has moved far beyond its traditional identity as the “pharmacy of the world” for generics.
Manufacturing | 01/01/2026 | By Darshana | 272
Corona Remedies to Expand Bhayla Manufacturing Capacity by 400 Million Units
Corona Remedies Limited has announced an expansion of manufacturing capacity at its Bhayla formulation facility to support rising demand for its products. The expansion will add 400 million units of tablet and capsule capacity, with 240 million units expected to be available for utilisation.
Manufacturing | 29/12/2025 | By Darshana | 176
Kashiv BioSciences Secures INR 684 Crore to Build Biopharma Facility
Kashiv BioSciences has secured INR 648 crore in financing from Union Bank of India to invest in a state-of-the-art biologics manufacturing facility in Pipan, Gujarat, aimed at strengthening technical capabilities, enhancing global competitiveness, and generating long-term, high-value employment across scientific, technical and operational roles.
Manufacturing | 26/12/2025 | By News Bureau | 216
Pluri and Remedy Cell Expand Partnership with Clinical-Grade Manufacturing Success
The duo have integrated Remedy Cell’s proprietary manufacturing process into Pluri’s GMP facility, completed GMP training and qualification for Remedy Cell’s manufacturing team, conducted engineering runs to validate process robustness and scalability, and produced multiple clinical-grade batches of Remedy Cell's lead candidate.
Manufacturing | 23/12/2025 | By News Bureau | 167
TempraMed Opens New Florida Manufacturing Facility to Boost Output and Cut Costs
TempraMed Technologies Ltd, a medical technology company focused on improving the storage and management of temperature-sensitive medications, has opened an additional manufacturing facility in Florida, strengthening its production footprint in the United States.
Manufacturing | 19/12/2025 | By Darshana | 189
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy